Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Blonde

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Managed Care (Langhorne, Pa.)|December 4, 2001
Management of type 2 diabetes: update on new pharmacological optionsL Blonde
Managed Care (Langhorne, Pa.)|December 4, 2001
Disease management approaches to type 2 diabetesL Blonde
Ochsner Journal|July 4, 2012
Epidemiology, costs, consequences, and pathophysiology of type 2 diabetes: an american epidemicL Blonde
Diabetes, Obesity & Metabolism|March 13, 2012
Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agentsL Blonde, E Montanya
The American Journal of Medicine|August 1, 1997
1997 ASP Leadership Conference: report on the status of subspecialty trainingL Blonde, P Ladenson
Diabetes Technology & Therapeutics|July 27, 2001
Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tabletL Blonde, M I Sandberg
Clinics in Laboratory Medicine|April 27, 2001
Classification of diabetes mellitusA A Kazi, L Blonde
Southern Medical Journal|October 1, 1976
Hypoglycemia: the "undisease"L Blonde, F A Riddick
Diabetes, Obesity & Metabolism|November 3, 2009
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studiesL Blonde, D Russell-Jones
The American Journal of Medicine|June 23, 1999
Assessing the quality of medical subspecialty training programsM J Kahn, L Blonde
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Managed Care (Langhorne, Pa.)|December 4, 2001
Management of type 2 diabetes: update on new pharmacological optionsL Blonde
Managed Care (Langhorne, Pa.)|December 4, 2001
Disease management approaches to type 2 diabetesL Blonde
Ochsner Journal|July 4, 2012
Epidemiology, costs, consequences, and pathophysiology of type 2 diabetes: an american epidemicL Blonde
Diabetes, Obesity & Metabolism|March 13, 2012
Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agentsL Blonde, E Montanya
The American Journal of Medicine|August 1, 1997
1997 ASP Leadership Conference: report on the status of subspecialty trainingL Blonde, P Ladenson
Diabetes Technology & Therapeutics|July 27, 2001
Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tabletL Blonde, M I Sandberg
Clinics in Laboratory Medicine|April 27, 2001
Classification of diabetes mellitusA A Kazi, L Blonde
Southern Medical Journal|October 1, 1976
Hypoglycemia: the "undisease"L Blonde, F A Riddick
Diabetes, Obesity & Metabolism|November 3, 2009
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studiesL Blonde, D Russell-Jones
The American Journal of Medicine|June 23, 1999
Assessing the quality of medical subspecialty training programsM J Kahn, L Blonde
Pageof 4